Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0015674 (chronic fatigue syndrome)
 2,978 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Magnetic resonance spectroscopy is one of the most important tools for quantitative analysis of chemical composition and structure, and this non-invasive technique is now being applied in vivo to study biochemical processes in those neuropsychiatric disorders that are part of the phospholipid spectrum. Interpretation of a clinical magnetic resonance spectrum can provide information about membrane phospholipid turnover, cellular energetics, neuronal function, selected neurotransmitter activity and intracellular pH. Cerebral proton and phosphorus magnetic resonance spectroscopy findings are summarized in relation to schizophrenia, dyslexia and chronic fatigue syndrome.
 ...
PMID:In vivo MR spectroscopy in diagnosis and research of neuropsychiatric disorders. 1504 Oct 27

Neurospectroscopy allows biochemical processes in the brain to be studied non-invasively. At magnetic field strengths of 1.5 T or higher, cerebral proton neurospectroscopy allows the ascertainment of values of myo-inositol, choline-containing compounds, creatine, glutamate, glutamine, and N-acetyl aspartate. At similar field strengths, cerebral 31-phosphorus neurospectroscopy allows the ascertainment of values of phosphomonoesters, inorganic phosphate, phosphodiesters, phosphocreatine, and the gamma, alpha and beta nucleotide triphosphate (mainly adenosine triphosphate) resonances. Since choline is a common polar head group at the Sn3 position of membrane phospholipid molecules, a raised level of free choline, as indexed by proton neurospectroscopy, can indicate relatively low anabolism of membrane phospholipid molecules. Furthermore, the choline peak includes phosphorylcholine and glycerophosphorylcholine and even ethanolamine. The phosphomonoesters peak measured using 31-phosphorus spectroscopy includes major contributions from phosphocholine, phosphoethanolamine and L-phosphoserine, which are important precursors of membrane phospholipids, while the phosphodiesters peak includes contributions from glycerophosphocholine and glycerophosphoethanolamine, which are important products of membrane phospholipid catabolism. Hence proton neurospectroscopy and 31-phosphorus neurospectroscopy can yield important information relating to the metabolism of cerebral membrane phospholipids. The application of these techniques to the investigation of membrane phospholipid metabolism in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis or M.E.) and dyslexia is described.
 ...
PMID:Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia. 1677 68

Prior investigations of scotopic sensitivity or Meares-Irlen syndrome have identified several features also found in attention deficit/hyperactivity disorder, chronic fatigue syndrome, and a subtype of dyslexia in which visual recognition is the primary deficit. In particular, anomalies in lipid metabolism, including low essential fatty acid status and decreased serum cholesterol, have been identified in all three disorders. Genetic expression of the transportermolecule apolipoprotein B-100 (APOB) has been correlated with abnormal lipid metabolism, particularly in relation to levels of cholesterol. Cholesterol esters are important carriers of essential fatty acids entering the retina. The APOB gene coding for apolipoprotein B-100 is located on the short arm of Chromosome 2, and closely neighbours a gene (DYX3) known to confer susceptibility to dyslexia. The APOB locus is also recognised as being one of the most highly polymorphic regions of the human genome, and thus provides a promising tool for genetic researchers. In this pilot study, certain allelic variants of the APOB gene were more common in participants diagnosed with Meares-Irlen syndrome than in individuals without the condition. This study appears to be a first in which a condition known to cause reading difficulties has been associated with the APOB gene.
 ...
PMID:A prospective genetic marker of the visual-perception disorder Meares-Irlen syndrome. 2291 27